Logest 0,02 mg/0,075 mg obložene tablete
| Name | Logest 0,02 mg/0,075 mg obložene tablete |
|---|---|
| Former Name | Logest obložene tablete |
| Marketing Authorisation Number | HR-H-466196823 |
| Active Substance | etinilestradiol gestoden |
| Composition | jedna obložena tableta sadrži 0,020 mg etinilestradiola i 0,075 mg gestodena |
| Pharmaceutical Form | obložena tableta |
| Packaging [MA Number for Packaging] | 21 tableta u blisteru, u kutiji [HR-H-466196823-01] |
| Manufacturer | Bayer AG, Berlin, Njemačka |
| Marketing Authorisation Holder | Bayer d.o.o., Radnička cesta 80, Zagreb, Hrvatska |
| Marketing Authorisation Date | 12.09.2018 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/445 |
| Registration Number | 381-12-01/30-18-06 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | G03AA10 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Educational materials for healthcare professionals |
Lista provjere za liječnike (verzija 1) Popratno pismo za liječnike Popratno pismo za ljekarnike |
| Educational materials for patients / caregivers |
Važne informacije za korisnicu (verzija 1) |
